Charles Bernick

Dr. Charles Bernick

Neurology
888 West Bonneville Avenue, 
Las Vegas, NV 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
50 Years of Experience
888 West Bonneville Avenue, 
Las Vegas, NV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Charles Bernick is a Neurologist in Las Vegas, Nevada. Dr. Bernick has been practicing medicine for over 50 years and is rated as an Experienced provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Alzheimer's Disease, Memory Loss, Dementia, and Lewy Body Dementia (LBD).

His clinical research consists of co-authoring 85 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Rice University, 1976.0
Residency
University of Miami Hospitals and Clinics
Specialties
Neurology
Licenses
Psychiatry & Neurology in WA
Board Certifications
American Board Of Psychiatry And Neurology, 1987
Fellowships
Arizona Health Sciences Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Cleveland Clinic Lou Ruvo Center for Brain Health - Las Vegas
888 West Bonneville Avenue, Las Vegas, NV 89106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
Enrollment Status: Recruiting
Publish Date: November 21, 2024
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects With Mild-to-Moderate Alzheimer's Disease
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Simufilam
Study Phase: Phase 3
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)
Enrollment Status: Completed
Publish Date: December 28, 2023
Intervention Type: Drug
Study Drug: Solanezumab
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
A Double-Blind, Placebo-Controlled 16-Week Study of the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Drug: Neflamapimod
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Drug
Study Drug: COR388
Study Phase: Phase 2/Phase 3
Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment (MCI)
Therapeutic Effects of Exercise in Adults With Amnestic Mild Cognitive Impairment (MCI)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Prazosin for Disruptive Agitation in Alzheimer's Disease (AD) (PEACE-AD)
Prazosin for Disruptive Agitation in Alzheimer's Disease (AD) (PEACE-AD)
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drug: Prazosin
Study Phase: Phase 2
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 10 Less Clinical Trials

85 Total Publications

Diffusion Alterations at the Gray Matter/White Matter Boundary in Traumatic Encephalopathy Syndrome.
Diffusion Alterations at the Gray Matter/White Matter Boundary in Traumatic Encephalopathy Syndrome.
Journal: Journal of neurotrauma
Published: November 11, 2025
Similar Doctors
Distinguished in Epilepsy
Dr. Venkatachalam Veerappan
Neurology
Distinguished in Epilepsy
Dr. Venkatachalam Veerappan
Neurology

Venkat Veerappan MD PC

3025 S Maryland Pkwy B, 
Las Vegas, NV 
 (2.4 miles away)
702-732-2600
Languages Spoken:
English, Malay, Spanish, Tamil
See accepted insurances
Accepting New Patients

Venkatachalam Veerappan is a Neurologist in Las Vegas, Nevada. Dr. Veerappan is rated as a Distinguished provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Seizures, Memory Loss, Chronic Inflammatory Demyelinating Polyneuropathy, Epilepsy, and Endovascular Embolization. Dr. Veerappan is currently accepting new patients.

Distinguished in Epilepsy
Dr. Kevin C. Xie
Neurology
Distinguished in Epilepsy
Dr. Kevin C. Xie
Neurology
5115 S Durango Dr, 
Las Vegas, NV 
 (8.6 miles away)
320-333-0789
Languages Spoken:
English, Filipino, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Kevin Xie is a Neurologist in Las Vegas, Nevada. Dr. Xie is rated as a Distinguished provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Seizures, Epilepsy, Memory Loss, and Cramp-Fasciculation Syndrome. Dr. Xie is currently accepting new patients.

Advanced in Epilepsy
Dr. Indranil Sen
Neurology
Advanced in Epilepsy
Dr. Indranil Sen
Neurology

Monitoring Associates LLC

9811 W Charleston Blvd Ste 2-641, 
Las Vegas, NV 
 (7.3 miles away)
855-864-4322
Languages Spoken:
English
See accepted insurances

Indranil Sen is a Neurologist in Las Vegas, Nevada. Dr. Sen is rated as a Distinguished provider by MediFind in the treatment of Epilepsy. His top areas of expertise are Seizures, Epilepsy, Cervical Myelopathy, and Memory Loss.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bernick's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 52 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile